PCVX Vaxcyte, Inc.
Fundamentals / CIK 0001649094 / USDVaxcyte, Inc. reported $2.99B in total assets and a net loss of $1.15B through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open PCVX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$1.23B Operating profit
-
Net Income FY 2025-$1.15B GAAP bottom line
-
Diluted EPS FY 2025-$7.71 Split-adjusted
-
Free Cash Flow FY 2025-$974.4M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$1.29B Total debt: $221.8M
Annual revenue and net income
8 fiscal years (2018 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $794.3M | $476.6M | $332.3M | $169.5M | $78.41M | $73.56M | $45.61M | $30.14M |
| Total Operating Expenses | $923.7M | $569.5M | $468.0M | $232.3M | $103.7M | $89.58M | $54.15M | $35.53M |
| Operating Income | -$923.7M | -$569.5M | -$468.0M | -$232.3M | -$103.7M | -$89.58M | -$54.15M | -$35.53M |
| EBITDA | -$907.3M | -$562.5M | -$464.9M | -$229.4M | -$101.9M | -$88.18M | -$52.92M | -$34.50M |
| Interest Income | $119.7M | $110.0M | $62.91M | $8.36M | $344K | $244K | $632K | $903K |
| Interest Expense | -- | $0 | $0 | $2.0K | $7.0K | $7.0K | $40K | $75K |
| Income Tax Expense | $0 | $0 | $0 | -- | -- | -- | -- | -- |
| Net Income | -$766.6M | -$463.9M | -$402.3M | -$223.5M | -$100.1M | -$89.22M | -$50.27M | -$29.48M |
| Basic EPS | -$5.63 | -$3.80 | -$4.14 | -$3.44 | -$1.93 | -$3.02 | -$13.25 | -$8.12 |
| Diluted EPS | -$5.63 | -$3.80 | -$4.14 | -$3.44 | -$1.93 | -$3.02 | -$13.25 | -$8.12 |
| Basic Shares Outstanding | 136.1M | 122.0M | 97.2M | 64.9M | 51.9M | 29.5M | 3.8M | 3.6M |
| Diluted Shares Outstanding | 136.1M | 122.0M | 97.2M | 64.9M | 51.9M | 29.5M | 3.8M | 3.6M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $270.3M | $267.9M | $312.8M | $242.1M | $209.9M | $194.2M | $148.1M | $133.6M |
| Total Operating Expenses | $308.3M | $302.8M | $345.9M | $274.3M | $242.4M | $226.2M | $180.8M | $162.2M |
| Operating Income | -$308.3M | -$302.8M | -$345.9M | -$274.3M | -$242.4M | -$226.2M | -$180.8M | -$162.2M |
| EBITDA | -$302.5M | -$299.8M | -$342.9M | -$266.8M | -$239.3M | -$223.3M | -$177.8M | -$159.3M |
| Interest Income | $23.19M | $25.75M | $26.61M | $26.45M | $29.26M | $31.07M | $32.94M | $36.46M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$297.1M | -$284.3M | -$320.6M | -$246.5M | -$212.8M | -$166.6M | -$140.7M | -$137.1M |
| Basic EPS | -$1.99 | -$1.97 | -$2.30 | -- | -$1.56 | -$1.22 | -$1.04 | -- |
| Diluted EPS | -$1.99 | -$1.97 | -$2.30 | -- | -$1.56 | -$1.22 | -$1.04 | -- |
| Basic Shares Outstanding | 148.9M | 144.5M | 139.5M | -- | 136.2M | 136.0M | 135.7M | -- |
| Diluted Shares Outstanding | 148.9M | 144.5M | 139.5M | -- | 136.2M | 136.0M | 135.7M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $174.0M | $387.9M | $397.5M | $834.7M | $68.98M | $386.2M | $58.98M |
| Short-Term Investments | $1.39B | $1.36B | $682.8M | $96.72M | $177.0M | -- | -- |
| Cash & Short-Term Investments | $1.56B | $1.75B | $1.08B | $931.4M | $246.0M | $386.2M | $58.98M |
| Other Current Assets | $1.59M | $2.04M | $2.11M | $1.99M | -- | -- | -- |
| Total Current Assets | $1.63B | $1.79B | $1.10B | $942.6M | $256.3M | $389.0M | $61.72M |
| Property, Plant & Equipment, Net | $257.4M | $198.0M | $79.63M | $10.36M | $7.95M | $3.27M | $3.39M |
| Long-Term Investments | $881.7M | $1.39B | $162.7M | $26.55M | $27.12M | -- | -- |
| Other Non-Current Assets | $118.8M | $64.36M | $37.56M | $4.55M | $4.09M | $550K | $584K |
| Total Non-Current Assets | $1.38B | $1.72B | $312.0M | $63.62M | $67.99M | $3.82M | $3.98M |
| Total Assets | $3.00B | $3.51B | $1.41B | $1.01B | $324.3M | $392.8M | $65.70M |
| Accounts Payable | $70.90M | $48.45M | $14.59M | $9.79M | $6.76M | $29.79M | $3.38M |
| Total Current Liabilities | $205.8M | $140.2M | $145.3M | $40.52M | $28.72M | $46.86M | $11.05M |
| Other Non-Current Liabilities | $100K | $100K | $0 | $9.0K | $96K | $112K | $242K |
| Total Non-Current Liabilities | $111.5M | $65.32M | $22.11M | $12.04M | $11.60M | $122K | $709K |
| Total Liabilities | $317.2M | $205.5M | $167.4M | $52.56M | $40.32M | $46.98M | $11.76M |
| Total Debt (incl. Leases) | $117.6M | $71.11M | $29.22M | $17.94M | $16.78M | -- | $161K |
| Common Stock | $134K | $128K | $98K | $82K | $56K | $54K | $7.0K |
| Retained Earnings | -$2.15B | -$1.39B | -$924.4M | -$522.1M | -$298.6M | -$198.6M | -$109.3M |
| Accumulated Other Comp. Income | $1.59M | -$3.87M | $179K | -$361K | -$241K | -- | -- |
| Total Stockholders' Equity | $2.69B | $3.31B | $1.24B | $953.6M | $284.0M | $345.8M | -$106.4M |
| Total Equity | $2.69B | $3.31B | $1.24B | $953.6M | $284.0M | $345.8M | -$106.4M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $125.5M | $183.2M | $260.8M | $174.0M | $281.1M | $306.7M | $346.9M | $387.9M |
| Short-Term Investments | $1.17B | $1.30B | $1.48B | $1.39B | $1.43B | $1.35B | $1.32B | $1.36B |
| Cash & Short-Term Investments | $1.29B | $1.49B | $1.74B | $1.56B | $1.71B | $1.66B | $1.67B | $1.75B |
| Other Current Assets | -- | -- | -- | $1.59M | -- | -- | -- | $2.04M |
| Total Current Assets | $1.35B | $1.55B | $1.81B | $1.63B | $1.77B | $1.72B | $1.72B | $1.79B |
| Property, Plant & Equipment, Net | $253.4M | $260.4M | $260.7M | $257.4M | $253.5M | $242.3M | $217.2M | $198.0M |
| Long-Term Investments | $972.2M | $1.02B | $1.00B | $881.7M | $959.3M | $1.17B | $1.28B | $1.39B |
| Other Non-Current Assets | $3.25M | $192.6M | $155.5M | $118.8M | $106.7M | $95.26M | $76.28M | $64.36M |
| Total Non-Current Assets | $1.64B | $1.59B | $1.53B | $1.38B | $1.40B | $1.59B | $1.66B | $1.72B |
| Total Assets | $2.99B | $3.14B | $3.35B | $3.00B | $3.17B | $3.31B | $3.38B | $3.51B |
| Accounts Payable | $67.61M | $100.9M | $63.06M | $70.90M | $48.96M | $31.41M | $20.51M | $48.45M |
| Total Current Liabilities | $295.7M | $271.3M | $242.1M | $205.8M | $200.0M | $154.5M | $97.00M | $140.2M |
| Other Non-Current Liabilities | -- | -- | -- | $100K | -- | -- | -- | $100K |
| Total Non-Current Liabilities | $204.2M | $108.9M | $110.2M | $111.5M | $78.67M | $79.54M | $81.08M | $65.32M |
| Total Liabilities | $499.9M | $380.2M | $352.3M | $317.2M | $278.7M | $234.0M | $178.1M | $205.5M |
| Total Debt (incl. Leases) | $221.8M | $115.4M | $116.3M | $117.6M | $84.44M | $85.84M | $87.11M | $71.11M |
| Common Stock | $152K | $148K | $147K | $134K | $133K | $133K | $132K | $128K |
| Retained Earnings | -$3.06B | -$2.76B | -$2.48B | -$2.15B | -$1.91B | -$1.70B | -$1.53B | -$1.39B |
| Accumulated Other Comp. Income | -$14.98M | -$7.55M | -$6.83M | $1.59M | $856K | -$1.89M | -$322K | -$3.87M |
| Total Stockholders' Equity | $2.49B | $2.76B | $3.00B | $2.69B | $2.89B | $3.07B | $3.20B | $3.31B |
| Total Equity | $2.49B | $2.76B | $3.00B | $2.69B | $2.89B | $3.07B | $3.20B | $3.31B |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$766.6M | -$463.9M | -$402.3M | -$223.5M | -$100.1M | -$89.22M | -$50.27M | -$29.48M |
| Depreciation & Amortization | $16.40M | $7.00M | $3.16M | $2.83M | $1.80M | $1.41M | $1.23M | $1.04M |
| Stock-Based Compensation | $138.8M | $84.82M | $48.76M | $23.65M | $10.73M | $5.43M | $1.19M | $749K |
| Change in Payables | $19.91M | $34.58M | $11.22M | $2.90M | -$12.47M | $26.10M | $868K | $1.27M |
| Operating Cash Flow | -$655.6M | -$452.6M | -$296.8M | -$170.6M | -$121.4M | -$46.63M | -$47.15M | -$30.47M |
| Capital Expenditure | -$13.71M | -$22.43M | -$16.06M | -$5.84M | -$6.55M | -$1.16M | -$1.20M | -$1.77M |
| Free Cash Flow | -$669.3M | -$475.1M | -$312.9M | -$176.4M | -$127.9M | -$47.78M | -$48.34M | -$32.24M |
| Purchases of Investments | -$1.21B | -$3.09B | -$1.33B | -$102.7M | -$336.3M | $0 | -- | -- |
| Sales & Maturities of Investments | $1.71B | $1.20B | $624.5M | $183.2M | $130.6M | $0 | -- | -- |
| Investing Cash Flow | $437.4M | -$2.01B | -$773.3M | $74.58M | -$212.3M | -$1.10M | -$1.20M | -$1.77M |
| Common Stock Issued | -- | $195.9M | $90.74M | $97.30M | $13.90M | $0 | -- | -- |
| Financing Cash Flow | $2.01M | $2.45B | $639.8M | $861.5M | $17.80M | $374.9M | $41.57M | $62.19M |
| Net Change in Cash | -$213.8M | -$9.36M | -$437.0M | $765.7M | -$316.3M | $327.2M | -$7.11M | $29.95M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$297.1M | -$284.3M | -$320.6M | -$246.5M | -$212.8M | -$166.6M | -$140.7M | -$137.1M |
| Depreciation & Amortization | $5.78M | $3.00M | $2.95M | $7.50M | $3.06M | $2.88M | $2.96M | $2.86M |
| Stock-Based Compensation | $41.10M | $41.24M | $37.96M | $36.00M | $35.31M | $36.93M | $30.61M | $24.37M |
| Change in Payables | -$32.86M | $31.55M | -$269K | $21.67M | $17.88M | $9.53M | -$29.16M | $31.31M |
| Operating Cash Flow | -$224.1M | -$232.5M | -$280.6M | -$224.8M | -$143.3M | -$121.2M | -$166.3M | -$111.4M |
| Capital Expenditure | -$3.33M | -$4.32M | -$2.11M | -$2.65M | -$3.82M | -$1.81M | -$5.42M | -$4.02M |
| Free Cash Flow | -$227.4M | -$236.8M | -$282.7M | -$227.5M | -$147.1M | -$123.0M | -$171.7M | -$115.4M |
| Purchases of Investments | -$236.3M | -$268.7M | -$584.1M | -$292.6M | -$255.3M | -$349.1M | -$314.5M | -$815.2M |
| Sales & Maturities of Investments | $412.0M | $421.0M | $365.5M | $416.2M | $388.5M | $436.5M | $464.6M | $288.1M |
| Investing Cash Flow | $170.8M | $147.7M | -$233.4M | $115.1M | $121.2M | $77.74M | $123.3M | -$557.2M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -$26K |
| Financing Cash Flow | -$5.33M | $5.70M | $601.6M | $2.41M | -$3.67M | $2.52M | $759K | $4.91M |
| Net Change in Cash | -$57.93M | -$77.65M | $86.88M | -$107.1M | -$25.52M | -$40.11M | -$41.03M | -$662.3M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -28.5% | -14.0% | -32.4% | -23.4% | -35.2% | -25.8% | -- | -- |
| Return on Assets (ROA) | -25.5% | -13.2% | -28.6% | -22.2% | -30.9% | -22.7% | -76.5% | -- |
| Current Ratio | 7.91x | 12.75x | 7.54x | 23.26x | 8.93x | 8.30x | 5.58x | -- |
| Quick Ratio | 7.59x | 12.46x | 7.43x | 22.98x | 8.57x | 8.24x | 5.34x | -- |
| Debt to Equity | 0.04x | 0.02x | 0.02x | 0.02x | 0.06x | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -46.1% | -38.6% | -31.6% | -28.5% | -22.7% | -17.8% | -15.9% | -14.0% |
| Return on Assets (ROA) | -38.4% | -33.9% | -28.3% | -25.5% | -20.7% | -16.6% | -15.1% | -13.2% |
| Current Ratio | 4.56x | 5.72x | 7.49x | 7.91x | 8.83x | 11.11x | 17.70x | 12.75x |
| Quick Ratio | 4.37x | 5.48x | 7.18x | 7.59x | 8.55x | 10.75x | 17.24x | 12.46x |
| Debt to Equity | 0.09x | 0.04x | 0.04x | 0.04x | 0.03x | 0.03x | 0.03x | 0.02x |